Anthracyclines are essential anticancer agents, yet a cardiomyocyte‐centered model incompletely explains why cardiac injury can be delayed, progressive, and poorly captured by rest
Permissive cardiotoxicity is an evolving clinical practice pattern that balances the management of cancer treatment‐associated cardiotoxicities with the risk of interrupting lifesa
Background Cardiometabolic risk associated with obesity is increasingly recognized to be strongly influenced by the anatomical distribution and ectopic deposition of adipose tissue
BACKGROUND: Stroke burden varies across the Americas, yet data on modifiable risk factor contributions remain limited. METHODS: Using GBD (Global Burden of Disease) study 2021 data
This is a consensus statement from multidisciplinary expert work groups convened by the American Heart Association to address clinical management gaps; it provides recommendations for practice but does not present original trial data or evidence synthesis.
A narrative review synthesizing pathophysiological mechanisms linking rheumatologic disease to HFpEF, identifying diagnostic and therapeutic gaps without reporting new primary evidence or quantitative outcomes.